286 related articles for article (PubMed ID: 24633463)
21. Demethyleneberberine attenuates non-alcoholic fatty liver disease with activation of AMPK and inhibition of oxidative stress.
Qiang X; Xu L; Zhang M; Zhang P; Wang Y; Wang Y; Zhao Z; Chen H; Liu X; Zhang Y
Biochem Biophys Res Commun; 2016 Apr; 472(4):603-9. PubMed ID: 26970305
[TBL] [Abstract][Full Text] [Related]
22. Ajoene, a stable garlic by-product, inhibits high fat diet-induced hepatic steatosis and oxidative injury through LKB1-dependent AMPK activation.
Han CY; Ki SH; Kim YW; Noh K; Lee DY; Kang B; Ryu JH; Jeon R; Kim EH; Hwang SJ; Kim SG
Antioxid Redox Signal; 2011 Jan; 14(2):187-202. PubMed ID: 20560786
[TBL] [Abstract][Full Text] [Related]
23. Ginsenoside Re lowers blood glucose and lipid levels via activation of AMP-activated protein kinase in HepG2 cells and high-fat diet fed mice.
Quan HY; Yuan HD; Jung MS; Ko SK; Park YG; Chung SH
Int J Mol Med; 2012 Jan; 29(1):73-80. PubMed ID: 21971952
[TBL] [Abstract][Full Text] [Related]
24. Persimmon tannin accounts for hypolipidemic effects of persimmon through activating of AMPK and suppressing NF-κB activation and inflammatory responses in high-fat diet rats.
Zou B; Ge ZZ; Zhang Y; Du J; Xu Z; Li CM
Food Funct; 2014 Jul; 5(7):1536-46. PubMed ID: 24841999
[TBL] [Abstract][Full Text] [Related]
25. Chronic treatment with the modified Longdan Xiegan Tang attenuates olanzapine-induced fatty liver in rats by regulating hepatic de novo lipogenesis and fatty acid beta-oxidation-associated gene expression mediated by SREBP-1c, PPAR-alpha and AMPK-alpha.
Ren L; Sun D; Zhou X; Yang Y; Huang X; Li Y; Wang C; Li Y
J Ethnopharmacol; 2019 Mar; 232():176-187. PubMed ID: 30590197
[TBL] [Abstract][Full Text] [Related]
26. Betulinic acid alleviates non-alcoholic fatty liver by inhibiting SREBP1 activity via the AMPK-mTOR-SREBP signaling pathway.
Quan HY; Kim DY; Kim SJ; Jo HK; Kim GW; Chung SH
Biochem Pharmacol; 2013 May; 85(9):1330-40. PubMed ID: 23435355
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of stearoyl-CoA desaturase1 activates AMPK and exhibits beneficial lipid metabolic effects in vitro.
Kim E; Lee JH; Ntambi JM; Hyun CK
Eur J Pharmacol; 2011 Dec; 672(1-3):38-44. PubMed ID: 21970804
[TBL] [Abstract][Full Text] [Related]
28. Effects of the new thiazolidine derivative LPSF/GQ-02 on hepatic lipid metabolism pathways in non-alcoholic fatty liver disease (NAFLD).
Araújo S; Soares E Silva A; Gomes F; Ribeiro E; Oliveira W; Oliveira A; Lima I; Lima MDC; Pitta I; Peixoto C
Eur J Pharmacol; 2016 Oct; 788():306-314. PubMed ID: 27349145
[TBL] [Abstract][Full Text] [Related]
29. Lipid accumulation stimulates the cap-independent translation of SREBP-1a mRNA by promoting hnRNP A1 binding to its 5'-UTR in a cellular model of hepatic steatosis.
Siculella L; Tocci R; Rochira A; Testini M; Gnoni A; Damiano F
Biochim Biophys Acta; 2016 May; 1861(5):471-81. PubMed ID: 26869449
[TBL] [Abstract][Full Text] [Related]
30. Hexacosanol reduces plasma and hepatic cholesterol by activation of AMP-activated protein kinase and suppression of sterol regulatory element-binding protein-2 in HepG2 and C57BL/6J mice.
Lee JH; Jia Y; Thach TT; Han Y; Kim B; Wu C; Kim Y; Seo WD; Lee SJ
Nutr Res; 2017 Jul; 43():89-99. PubMed ID: 28676202
[TBL] [Abstract][Full Text] [Related]
31. α-Terpineol induces fatty liver in mice mediated by the AMP-activated kinase and sterol response element binding protein pathway.
Choi YJ; Sim WC; Choi HK; Lee SH; Lee BH
Food Chem Toxicol; 2013 May; 55():129-36. PubMed ID: 23274539
[TBL] [Abstract][Full Text] [Related]
32. Polydatin alleviates non-alcoholic fatty liver disease in rats by inhibiting the expression of TNF-α and SREBP-1c.
Zhang J; Tan Y; Yao F; Zhang Q
Mol Med Rep; 2012 Oct; 6(4):815-20. PubMed ID: 22858825
[TBL] [Abstract][Full Text] [Related]
33. Water Extract of Dolichos lablab Attenuates Hepatic Lipid Accumulation in a Cellular Nonalcoholic Fatty Liver Disease Model.
Im AR; Kim YH; Lee HW; Song KH
J Med Food; 2016 May; 19(5):495-503. PubMed ID: 27152979
[TBL] [Abstract][Full Text] [Related]
34. Viscothionin isolated from Korean mistletoe improves nonalcoholic fatty liver disease via the activation of adenosine monophosphate-activated protein kinase.
Kim S; Lee D; Kim JK; Kim JH; Park JH; Lee JW; Kwon J
J Agric Food Chem; 2014 Dec; 62(49):11876-83. PubMed ID: 25383453
[TBL] [Abstract][Full Text] [Related]
35. The inhibition of oleic acid induced hepatic lipogenesis and the promotion of lipolysis by caffeic acid via up-regulation of AMP-activated kinase.
Liao CC; Ou TT; Huang HP; Wang CJ
J Sci Food Agric; 2014 Apr; 94(6):1154-62. PubMed ID: 24027117
[TBL] [Abstract][Full Text] [Related]
36. Resveratrol improves hepatic steatosis by inducing autophagy through the cAMP signaling pathway.
Zhang Y; Chen ML; Zhou Y; Yi L; Gao YX; Ran L; Chen SH; Zhang T; Zhou X; Zou D; Wu B; Wu Y; Chang H; Zhu JD; Zhang QY; Mi MT
Mol Nutr Food Res; 2015 Aug; 59(8):1443-57. PubMed ID: 25943029
[TBL] [Abstract][Full Text] [Related]
37. Resveratrol attenuates hepatic steatosis in high-fat fed mice by decreasing lipogenesis and inflammation.
Andrade JM; Paraíso AF; de Oliveira MV; Martins AM; Neto JF; Guimarães AL; de Paula AM; Qureshi M; Santos SH
Nutrition; 2014; 30(7-8):915-9. PubMed ID: 24985011
[TBL] [Abstract][Full Text] [Related]
38. The Dipeptidyl Peptidase-4 Inhibitor Teneligliptin Attenuates Hepatic Lipogenesis via AMPK Activation in Non-Alcoholic Fatty Liver Disease Model Mice.
Ideta T; Shirakami Y; Miyazaki T; Kochi T; Sakai H; Moriwaki H; Shimizu M
Int J Mol Sci; 2015 Dec; 16(12):29207-18. PubMed ID: 26670228
[TBL] [Abstract][Full Text] [Related]
39. A conjugated fatty acid present at high levels in bitter melon seed favorably affects lipid metabolism in hepatocytes by increasing NAD(+)/NADH ratio and activating PPARα, AMPK and SIRT1 signaling pathway.
Chen GC; Su HM; Lin YS; Tsou PY; Chyuan JH; Chao PM
J Nutr Biochem; 2016 Jul; 33():28-35. PubMed ID: 27260465
[TBL] [Abstract][Full Text] [Related]
40. The hypotriglyceridemic effect of biotin supplementation involves increased levels of cGMP and AMPK activation.
Aguilera-Méndez A; Fernández-Mejía C
Biofactors; 2012; 38(5):387-94. PubMed ID: 22806917
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
